Conferences

Catalog

Abstracts

Calendar

The International Gynecologic Oncology Consensus Conference: Marrying Evidence to Practice

Name: The International Gynecologic Oncology Consensus Conference: Marrying Evidence to Practice
Start: 2026-11-06T08:00:00+00:00
End: 2026-11-07T08:00:00+00:00
Location: Hyatt Regency Boston

Venue: Hyatt Regency Boston, One Avenue de Lafayette, Boston, MA, United States

Start Date: November 6End Date: November 7, 2026

Overview

Trusted by Thousands of Attendees
Across Our Events

Email if you have questions

Our Agenda

Day 1: Friday, November 6th, 2026

All timings are in Eastern Time (EDT, GMT-04:00) time.

01:00 PM - 01:20 PMWelcome & Meeting Introduction

01:20 PM - 02:30 PMApplying Precision Therapy in the Adjuvant Setting (Part One)

Session Chair: Anuja Jhingran

01:20 PM - 01:40 PM

Molecular staging of endometrial cancer: approach to p53 abnormal tumors – Carol Aghajanian

01:40 PM - 02:00 PM

A critical review of the role of radiation in early-stage endometrial cancer – Ann Klopp

02:00 PM - 02:15 PM

Discussion

02:15 PM - 02:30 PM

Vote (audience participation, panel vote)

02:30 PM - 02:45 PMBreak & Exhibits

02:45 PM - 03:55 PMApplying Precision Therapy in the Adjuvant Setting (Part One)

Session Chair: Stephanie Lherueux

02:45 PM - 03:05 PM

Adjuvant PARP inhibitors: Update on long-term benefit

03:05 PM - 03:25 PM

Is there a role for PARPi after progression on a prior PARPi?

03:25 PM - 03:40 PM

Discussion

03:40 PM - 03:55 PM

Vote (audience participation, panel vote)

03:55 PM - 04:05 PMBreak & Exhibits

04:05 PM - 05:30 PMADCs in Gynecologic Cancer

Session Chair: Linda Duska

04:05 PM - 04:25 PM

The current state of FOLR1 directed treatments: mirvetuximab and beyond

04:25 PM - 04:45 PM

B96 Trial – Domenica Lorusso

04:45 PM - 05:00 PM

Rosella

05:00 PM - 05:15 PM

Discussion

05:15 PM - 05:30 PM

Vote (audience participation, panel vote)

Day 2: Saturday, November 7th, 2026

08:05 AM - 08:10 AMWelcome

08:10 AM - 09:25 AMADCs in Gynecologic Cancer (Continued)

Session Chair: Dmitriy Zamarin

08:10 AM - 08:30 AM

The role of ADCs in endometrial cancer

08:30 AM - 08:50 AM

Targeting HER2: is earlier better?

08:50 AM - 09:10 AM

Discussion

09:10 AM - 09:25 AM

Vote (audience participation, panel vote)

09:25 AM - 09:40 AMBreak & Exhibits

09:40 AM - 11:45 AMApplying Precision Therapy in the Adjuvant Setting (Part Two)

Session Chair: Katina Robison

09:40 AM - 10:00 AM

The role of checkpoint inhibitors in dMMR endometrial cancer – Ramez Eskander

10:00 AM - 10:20 AM

Options and endpoints with adjuvant RT for endometrial cancer

10:20 AM - 10:40 AM

POLE-endometrial cancer: Does stage matter?

10:40 AM - 11:00 AM

A critical evaluation of checkpoint inhibitors in cervical cancer: PD-L1 and beyond

11:00 AM - 11:30 AM

Discussion

11:30 AM - 11:45 AM

Vote (audience participation, panel vote)

11:45 AM - 01:00 PMLunch & Exhibits

01:00 PM - 02:45 PMClinical Equipoise in Gynecologic Cancer

01:00 PM - 01:20 PM

A look at primary treatment of cervical cancer: Making sense of A18 and Interlace

01:20 PM - 01:40 PM

The role of surgery in metastatic endometrial cancer

01:40 PM - 02:00 PM

MRD monitoring in ovarian cancer: Time has come or not just yet?

02:00 PM - 02:30 PM

Discussion

02:30 PM - 02:45 PM

Vote (audience participation, panel vote)

About The International Gynecologic Oncology Consensus Conference: Marrying Evidence to Practice

Overview

Conference program and agenda

Our Agenda

Venue and map

Registration and pricing

Exhibitors and sponsorship

Our Agenda